Related Articles
Treatments for newly diagnosed multiple myeloma: analysis of survival data and cost-effectiveness evaluation.
Cost-effectiveness of neoadjuvant multimodal therapy in patients with esophageal adenocarcinoma
Cost‑effectiveness analysis of the addition of bevacizumab to temozolomide therapy for the treatment of unresected glioblastoma
PALLIATIVE RADIOTHERAPY FOR BRAIN METASTASES
Comparing the cost-effectiveness of FOLFIRINOX, nab-paclitaxel plus gemcitabine, gemcitabine and S-1 for the treatment of metastatic pancreatic cancer